Pulmatrix Inc (PULM)

[riskon]

$PULM Funny how people think JnJ ended the partnership.

I don't think so.

2010: JnJ buys RespiVert NSKI portfolio for $150M

2010-2017: JnJ fails to develop internally and with partner an inhaled version of their NSKI portfolio with acceptable safety standards/target efficacy

2017: JnJ Licenses NSKI portfolio to Pulmatrix with exclusive worldwide rights to commercialize and develop

2020: Pulmatrix re-licenses back iSPERSE enabled NSKI portfolio to JnJ on PUR1800

2021: JnJ terminates the re-license back of PUR1800

Everyone's focused on the termination of the relicense of PU1800 back to JnJ...

But what remains...

The NSKI portfolio exclusively granted to Pulmatrix is a bonded long-term partnership...

Maybe JnJ has other priorities. Like inhaled vaccines, repurposing or combining drugs for Covid Therapies, or even a buyout/carveout.

"All Pipelines fully funded " was to secure the company's ability to independently pursue each pipeline. Rhonda probably advised on that.